Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib.

MLA

Jiménez-Fonseca, Paula, et al. “Biomarkers and Polymorphisms in Pancreatic Neuroendocrine Tumors Treated with Sunitinib.” Oncotarget, vol. 9, no. 97, Dec. 2018, pp. 36894–905. EBSCOhost, https://doi.org/10.18632/oncotarget.26380.

APA

Jiménez-Fonseca, P., Martín, M. N., Carmona-Bayonas, A., Calvo, A., Fernández-Mateos, J., Redrado, M., Capdevila, J., Lago, N. M., Lacasta, A., Muñarriz, J., Segura, Á., Fuster, J., Barón, F., Llanos, M., Serrano, R., Castillo, A., Cruz Hernández, J. J., & Grande, E. (2018). Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib. Oncotarget, 9(97), 36894–36905. https://doi.org/10.18632/oncotarget.26380

Chicago

Jiménez-Fonseca, Paula, Miguel Navarro Martín, Alberto Carmona-Bayonas, Alfonso Calvo, Javier Fernández-Mateos, Miriam Redrado, Jaume Capdevila, et al. 2018. “Biomarkers and Polymorphisms in Pancreatic Neuroendocrine Tumors Treated with Sunitinib.” Oncotarget 9 (97): 36894–905. doi:10.18632/oncotarget.26380.